tiprankstipranks
Advertisement
Advertisement
GT Biopharma submits IND application to U.S. FDA for GTB-5550 TriKE
PremiumThe FlyGT Biopharma submits IND application to U.S. FDA for GTB-5550 TriKE
3M ago
GT Biopharma price target lowered to $8 from $11 at Roth Capital
Premium
The Fly
GT Biopharma price target lowered to $8 from $11 at Roth Capital
4M ago
GT Biopharma reports Q3 net loss $3.1M vs $3.4M last year
Premium
The Fly
GT Biopharma reports Q3 net loss $3.1M vs $3.4M last year
5M ago
GT Biopharma Waives Series L Stock Redemption Rights
PremiumCompany AnnouncementsGT Biopharma Waives Series L Stock Redemption Rights
6M ago
GT Biopharma Reports Reduced Losses Amid Ongoing Challenges
Premium
Company Announcements
GT Biopharma Reports Reduced Losses Amid Ongoing Challenges
7M ago
GT Biopharma Renews CEO Michael Breen’s Contract
Premium
Company Announcements
GT Biopharma Renews CEO Michael Breen’s Contract
7M ago
GT Biopharma Amends Share Purchase Agreement
PremiumCompany AnnouncementsGT Biopharma Amends Share Purchase Agreement
10M ago
GT Biopharma Reports Improved Quarterly Losses
Premium
Company Announcements
GT Biopharma Reports Improved Quarterly Losses
10M ago
GT Biopharma Expands Convertible Preferred Stock Offering
Premium
Company Announcements
GT Biopharma Expands Convertible Preferred Stock Offering
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100